Good Laboratory Practice for Nonclinical Studies (Drugs and the Pharmaceutical Sciences)

個数:

Good Laboratory Practice for Nonclinical Studies (Drugs and the Pharmaceutical Sciences)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 194 p.
  • 言語 ENG
  • 商品コード 9781032381152
  • DDC分類 363.1920973078

Full Description

The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.

• Unique volume covering FDA inspections of GLP facilities

• Provides a detailed interpretation of GLP Regulations

• Presents the latest on electronic data management in GLP

• Describes GLP and computer systems validation

• Can be referenced repeatedly in supporting daily hands on implementation of the CFR requirements

Contents

Introduction

1. Subpart A - General Provisions

i) Sec. 58.1 Scope

ii) Sec. 58.3 Definitions.

iii) Sec. 58.10 Applicability to studies performed under grants and contracts.

iv) Sec. 58.15 Inspection of a testing facility.

2. Subpart B - Organization and Personnel

i) Sec. 58.29 Personnel.

ii) Sec. 58.31 Testing facility management.

iii) Sec. 58.33 Study director

iv) Sec. 58.35 Quality assurance unit.

3. Subpart C - Facilities

i) Sec. 58.41 General.

ii) Sec. 58.43 Animal care facilities.

iii) Sec. 58.45 Animal supply facilities.

iv) Sec. 58.47 Facilities for handling test and control articles.

v) Sec. 58.49 Laboratory operation areas

vi) Sec. 58.51 Specimen and data storage facilities

4. Subpart D - Equipment

i) Sec. 58.61 Equipment design.

ii) Sec. 58.63 Maintenance and calibration of equipment.

5. Subpart E - Testing Facilities Operation

i) Sec. 58.81 Standard operating procedures.

ii) Sec. 58.83 Reagents and solutions.

iii) Sec. 58.90 Animal care.

6. Subpart F - Test and Control Articles

i) Sec. 58.107 Test and control article handling.

ii) Sec. 58.113 Mixtures of articles with carriers.

7. Subpart G - Protocol for and Conduct of a Nonclinical Laboratory Study

i) Sec. 58.120 Protocol.

ii) Sec. 58.130 Conduct of a nonclinical laboratory study.

8. Subpart J - Records and Reports

i) Sec. 58.185 Reporting of nonclinical laboratory study results.

ii) Sec. 58.190 Storage and retrieval of records and data.

9. Subpart K - Disqualification of Testing Facilities i) Sec. 58.200 Purpose.

ii) Sec. 58.202 Grounds for disqualification.

iii) Sec. 58.204 Notice of and opportunity for hearing on proposed disqualification.

iv) Sec. 58.210 Actions upon disqualification.

v) Sec. 58.213 Public disclosure of information regarding disqualification.

vi) Sec. 58.217 Suspension or termination of a testing facility by a sponsor.

vii) Sec. 58.219 Reinstatement of a disqualified testing facility.

10. Data Integrity: Paper and Electronic 21CFR11

最近チェックした商品